Last reviewed · How we verify
Ropivacaine plus dexmedetomidine
Ropivacaine plus dexmedetomidine is a Small molecule drug developed by Universidad Autónoma de Tamaulipas. It is currently in Phase 1 development.
At a glance
| Generic name | Ropivacaine plus dexmedetomidine |
|---|---|
| Sponsor | Universidad Autónoma de Tamaulipas |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine (PHASE4)
- PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults (NA)
- Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (NA)
- Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- PENG Block With Dexmedetomidine in Older Adults (NA)
- Tubeless Strategy in Lung Transplantation: A Prospective Single-Arm Study (NA)
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ropivacaine plus dexmedetomidine CI brief — competitive landscape report
- Ropivacaine plus dexmedetomidine updates RSS · CI watch RSS
- Universidad Autónoma de Tamaulipas portfolio CI
Frequently asked questions about Ropivacaine plus dexmedetomidine
What is Ropivacaine plus dexmedetomidine?
Ropivacaine plus dexmedetomidine is a Small molecule drug developed by Universidad Autónoma de Tamaulipas.
Who makes Ropivacaine plus dexmedetomidine?
Ropivacaine plus dexmedetomidine is developed by Universidad Autónoma de Tamaulipas (see full Universidad Autónoma de Tamaulipas pipeline at /company/universidad-aut-noma-de-tamaulipas).
What development phase is Ropivacaine plus dexmedetomidine in?
Ropivacaine plus dexmedetomidine is in Phase 1.